Topotecan: A review of its potential in advanced ovarian cancer

Drugs

Volumn 56, Issue 4, 1998, Pages 709-723

  Brogden, R N ^a   Wiseman, L R ^a   Noble, S ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL; TOPOTECAN;

ADVANCED CANCER; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER CELL; CLINICAL TRIAL; CYTOTOXICITY; DNA DAMAGE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; NAUSEA; NEUTROPENIA; OVARY CANCER; RELAPSE; THROMBOCYTOPENIA; VOMITING;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; OVARIAN NEOPLASMS; TOPOTECAN;

FALLOPIA;

EID: 0031736902     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856040-00017     Document Type: Article

References (73)